---
figid: PMC4383369__BMRI2015-568408.001
figtitle: Eicosanoid synthesis pathways
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
pmcid: PMC4383369
filename: BMRI2015-568408.001.jpg
figlink: /pmc/articles/PMC4383369/figure/fig1/
number: F1
caption: 'Eicosanoid synthesis pathways. After cell stimulation, arachidonic acid
  (AA) can be metabolized by three enzymes: cyclooxygenase (COX), lipoxygenase (LOX),
  and cytochrome P450 (CYP 450). COX catalyzes AA in (prostaglandin) PGG2 and PGH2,
  and these are converted into PGD2, PGE2, PGF2α, PG12, TXA1, and TXA2. The LOX pathway
  catalyzes AA into hydroxyeicosatetraenoic acids (HETEs) and diverse hydroperoxyeicosatetraenoic
  acids (HPETEs). This pathway involves four enzymes: 5-LOX, 8-LOX, 12-LOX, and 15-LOX.
  5-LOX interacts with a 5-LOX-activating protein (FLAP), enhancing the interaction
  of 5-LOX to AA. LTA4 hydrolases convert LTA4 into LTB4, and LTC4 synthase can convert
  LTA4 to LTC4, whereupon it is then metabolized to LTD4 and LTE4. 5-LOX synthetizes
  LXA4 and LXB4 using 15-HETE. The pathway of CYP-450 leads to the conversion of HETEs,
  including 16-, 17-, 18-, 19-, and 20-HETE and epoxyeicosatrienoic acids (EETs):
  5,6-, 8,9-, 11,12-, and 14,15-EET.'
papertitle: 'Lipid Mediators Are Critical in Resolving Inflammation: A Review of the
  Emerging Roles of Eicosanoids in Diabetes Mellitus.'
reftext: Fernando H. G. Tessaro, et al. Biomed Res Int. 2015;2015:568408.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9220623
figid_alias: PMC4383369__F1
figtype: Figure
organisms_ner:
- NA
redirect_from: /figures/PMC4383369__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4383369__BMRI2015-568408.001.html
  '@type': Dataset
  description: 'Eicosanoid synthesis pathways. After cell stimulation, arachidonic
    acid (AA) can be metabolized by three enzymes: cyclooxygenase (COX), lipoxygenase
    (LOX), and cytochrome P450 (CYP 450). COX catalyzes AA in (prostaglandin) PGG2
    and PGH2, and these are converted into PGD2, PGE2, PGF2α, PG12, TXA1, and TXA2.
    The LOX pathway catalyzes AA into hydroxyeicosatetraenoic acids (HETEs) and diverse
    hydroperoxyeicosatetraenoic acids (HPETEs). This pathway involves four enzymes:
    5-LOX, 8-LOX, 12-LOX, and 15-LOX. 5-LOX interacts with a 5-LOX-activating protein
    (FLAP), enhancing the interaction of 5-LOX to AA. LTA4 hydrolases convert LTA4
    into LTB4, and LTC4 synthase can convert LTA4 to LTC4, whereupon it is then metabolized
    to LTD4 and LTE4. 5-LOX synthetizes LXA4 and LXB4 using 15-HETE. The pathway of
    CYP-450 leads to the conversion of HETEs, including 16-, 17-, 18-, 19-, and 20-HETE
    and epoxyeicosatrienoic acids (EETs): 5,6-, 8,9-, 11,12-, and 14,15-EET.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - 5-HETE
  - 5-HPETE
  - 15-HETE
  - 11-HETE
  - 14,15-EET
  - 11,12-EET
  - 18-HETE
  - 16-HETE
  - 17-HETE
  - PGE2
  - 12-HETE
---
